MORNINGSIDE VENTURE PARTNERS
Morningside Venture Partners focuses on partnering with talented entrepreneurs to develop the next wave of truly great companies. Their team is comprised of a carefully curated group of angel investors from investment banking and management consulting platforms worldwide.
MORNINGSIDE VENTURE PARTNERS
Industry:
Finance Financial Services Venture Capital
Founded:
2018-01-01
Status:
Closed
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Amazon
Similar Organizations
Synthesis Venture Fund Partners
Synthesis Venture Fund Partners provides long-term partnerships with corporations and entrepreneurs for innovation and value creation.
Current Employees Featured
Dilip Rao Co-Founder @ Morningside Venture Partners
Co-Founder
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-09-07 | Otolith Labs | Morningside Venture Partners investment in Series A - Otolith Labs | 20 M USD |
| 2022-01-26 | CellCentric | Morningside Venture Partners investment in Venture Round - CellCentric | N/A |
| 2021-11-03 | Prilenia | Morningside Venture Partners investment in Series B - Prilenia | 43 M USD |
| 2021-04-08 | Alyce | Morningside Venture Partners investment in Series B - Alyce | 30 M USD |
| 2020-10-28 | Gracell Biotechnologies | Morningside Venture Partners investment in Series C - Gracell Biotechnologies | 100 M USD |
| 2020-06-16 | Greenlight Biosciences | Morningside Venture Partners investment in Series D - Greenlight Biosciences | 102 M USD |
| 2019-06-10 | Alyce | Morningside Venture Partners investment in Series A - Alyce | 11.5 M USD |
| 2018-06-12 | Epivax Oncology | Morningside Venture Partners investment in Venture Round - Epivax Oncology | 1.2 M USD |
| 2018-05-15 | CellCentric | Morningside Venture Partners investment in Venture Round - CellCentric | 26 M USD |
| 2018-04-02 | LyncMed | Morningside Venture Partners investment in Series A - LyncMed | 17.5 M USD |
More informations about "Morningside Venture Partners"
Morningside
The Morningside group invests private-equity and venture capital in novel science and technology sectors and is committed to social responsibility.See details»
Morningside Venture Partners - Crunchbase
Morningside Venture Partners focuses on partnering with talented entrepreneurs to develop the next wave of truly great companies. Their team is comprised of a carefully curated group of angel investors from investment banking and …See details»
Morningside Group investment portfolio - PitchBook
Founded in 1986, Morningside makes venture capital investments in companies with novel science and technology. Based in the greater Boston area, their team of entrepreneurial investment professionals has experience in life sciences, …See details»
Morningside Venture Partners company information, funding
Morningside Venture Partners. Save Request enhancement Edit profile. Save. New York City-based collective of leading investment professionals and business builders. HQ location. New …See details»
Morningside Venture Partners – Investors Database - Unicorn Nest
Morningside Venture Partners appeared to be the VC, which was created in 1986. The main department of described VC is located in the Shanghai. ... Takeda Ventures. This organization …See details»
Morningside Venture Partners - CB Insights
Sep 13, 2023 Morningside Venture Partners has made 13 investments. Their latest investment was in Generate Biomedicines as part of their Series C on September 14, 2023. Morningside …See details»
Morningside Venture Partners | Companies | Mindmaps
Morningside Venture Partners focuses on partnering with talented entrepreneurs to develop the next wave of truly great companies. Their team is comprised of a carefully curated group of …See details»
Morningside Venture Partners - Investments, Portfolio & Company …
Morningside Venture Partners has made 2 diversity investments. Their most recent diversity investment was on Jun 16, 2020, when Greenlight Biosciences raised. obfuscated. …See details»
Morningside - The Org
Morningside makes venture capital investments in companies with novel science and technology. We are characterized by a long-term outlook in company-building and an unwavering …See details»
Biotech - Morningside
Tomorrow . Portfolio › Venture › Biotech Anti-Infectives Vaccines Oncology Immune Disorders Neurology Sleep Cardiovascular, Renal and Metabolism Diagnostics Mitochondria …See details»
Morningside Group - vcinvestorlist.com
Morningside Group invests in private equity and venture capital opportunities. Number of Investments: 163 Number of Exits: 33 Investment Industries: Biotechnology;Finance;Financial …See details»
Contact - Morningside
Morningside makes venture capital investments in companies with novel science and technology. We are characterized by a long-term outlook in company-building and an unwavering …See details»
Morningside - Crunchbase Investor Profile & Investments
Morningside makes venture capital investments in companies with novel science and technology. We are characterized by a long-term outlook in company-building and an unwavering …See details»
Portfolio - Morningside
The Morningside group invests private-equity and venture capital in novel science and technology sectors and is committed to social responsibility.See details»
Tech - Morningside
Portfolio › Venture › Tech Catalant By providing a marketplace structure to the freelance economy, Catalant enables companies to quickly find elite independent experts to complete …See details»
Venture - Morningside
The Morningside group invests private-equity and venture capital in novel science and technology sectors and is committed to social responsibility.See details»
Ask a VC with Moe Kermani of Vanedge Capital - LinkedIn
Sep 12, 2014 In this installment of our “Ask A VC” segment, we sit with Moe Kermani of Vanedge Capitalfrom Vancouver, Canada. Moe has roots as an entrepreneur having co …See details»
Corporate venture building for CEOs | McKinsey - McKinsey
Oct 22, 2024 For the past five years, results from McKinsey Global Surveys on corporate venture building—also known as “new-business building,” which was the term used in the …See details»
William "Todd" Hancock - Portfolio Analyst at Virginia Innovation ...
Supports or leads Virginia Venture Partners’ Annual Survey of portfolio companies to gather performance and impact data ... * Built the organization into a perennial top performer, …See details»
Team | RQ Partners LLP.
John Quaglietta, a founding partner of RQ Partners, LLP., obtained his Bachelor of Laws degree from Osgoode Hall Law School in 1993 and served his articles of clerkship with a Vaughan …See details»